✦ LIBER ✦

Outcomes after induction chemotherapy in patients with acute myeloid leukemia arising from myelodysplastic syndrome

✍ Scribed by Celeste Bello; Daohai Yu; Rami S. Komrokji; Weiwei Zhu; Gene A. Wetzstein; Alan F. List; Jeffrey E. Lancet

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 202 KB
Volume: 117
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.25598

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acute pulmonary failure during remission

Acute pulmonary failure during remission induction chemotherapy in adults with acute myeloid leukemia or high-risk myelodysplastic syndrome

✍ Ali Al Ameri; Charles Koller; Hagop Kantarjian; Farhad Ravandi; Srdan Verstovsek 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB 👁 2 views

Simultaneous expression of lymphoid and

Simultaneous expression of lymphoid and myeloid phenotypes in acute leukemia arising from myelodysplastic syndrome

✍ Dr. Norio Komatsu; Minoru Yoshida; Mitsuoki Eguchi; Makoto Akashi; Ryuhei Sasaki 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 360 KB 👁 2 views

Insufficient outcomes with imatinib mesy

Insufficient outcomes with imatinib mesylate: Case report of Ph-positive acute myeloid leukemia evolving from myelodysplastic syndrome

✍ Atsushi Isoda; Hirotaka Nakahashi; Takumi Hoshino; Takeki Mitsui; Yasushi Yoshid 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 314 KB 👁 2 views

Reversible posterior leukoencephalopathy

Reversible posterior leukoencephalopathy syndrome after repeat intermediate-dose cytarabine chemotherapy in a patient with acute myeloid leukemia

✍ Bungo Saito; Tsuyoshi Nakamaki; Hidetoshi Nakashima; Takako Usui; Norimichi Hatt 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 2 views

## Abstract A 56‐year‐old man was admitted to our hospital with leukocytosis, anemia, and thrombocytopenia. Acute monoblastic leukemia was diagnosed. Two subsequent courses of consolidation chemotherapy consisted of conventional doses of cytarabine and intermediate‐dose cytarabine. Intermediate‐dos

Superior outcome with hypomethylating th

Superior outcome with hypomethylating therapy in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome and chromosome 5 and 7 abnormalities

✍ Farhad Ravandi; Jean-Pierre Issa; Guillermo Garcia-Manero; Susan O'Brien; Sherry 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views

Results of intensive chemotherapy in 998

Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: : Predictive prognostic models for outcome

✍ Hagop Kantarjian; Susan O'Brien; Jorge Cortes; Francis Giles; Stefan Faderl; Eli 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 1 views

## Abstract ## BACKGROUND Elderly patients (age ≥ 65 years) with acute myeloid leukemia (AML) generally have a poor prognosis. AML‐type therapy results are often derived from studies in younger patients and may not apply to elderly AML. Many investigators and oncologists advocate, at times, only s